Tenaya Therapeutics secures $106M
March 2, 2021- Share:
Tenaya Therapeutics has raised a $106 million Series C led by RTW Investments. The Bay Area company is developing therapies to address cardiovascular disease, with a focus on gene therapy, cellular regeneration and precision medicine. Tenaya raised $92 million at a $210 million valuation in 2019, according to PitchBook data.
Additional Investors
- Share:
-
-
-
-